English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Can Delta Radiomics Improve the Prediction of Best Overall Response, Progression-Free Survival, and Overall Survival of Melanoma Patients Treated with Immune Checkpoint Inhibitors?

MPS-Authors
/persons/resource/persons289328

Gatidis,  Sergios
Dept. Empirical Inference, Max Planck Institute for Intelligent Systems, Max Planck Society;
External Organizations;

Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Peisen, F., Gerken, A., Hering, A., Dahm, I., Nikolaou, K., Gatidis, S., et al. (2026). Can Delta Radiomics Improve the Prediction of Best Overall Response, Progression-Free Survival, and Overall Survival of Melanoma Patients Treated with Immune Checkpoint Inhibitors? Cancers / Molecular Diversity Preservation International (MDPI), 16(15): 2669. doi:10.3390/cancers16152669.


Cite as: https://hdl.handle.net/21.11116/0000-0010-5FC0-B
Abstract
There is no abstract available